| NCT ID | NCT02713529 |
| Title | Safety Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | no |
| Sponsors | Amgen |
| Indications | |
| Therapies | |
| Age Groups: | adult |